Fichero a descargar de la publicación mostrada - Sociedad ...

Octubre 2011 INFECCIONES RELACIONADAS CON CATÉTERES VASCULARES Pág. 58______________________________________________________________________________298. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ. A randomized, controlled trial of a new vascularcatheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol2005; 26:520-4.299. Abbas SA, Haloob IA, Taylor SL, et al. Effect of antimicrobial locks for tunneled hemodialysis catheters onbloodstream infection and bacterial resistance: a quality improvement report. Am J Kidney Dis 2009; 53:492-502.300. Morales-Molina JA, Mateu-de AJ, Grau S, Segura M, Acosta P. [Stability: a factor to consider in antibioticlocksolutions]. Enferm Infecc Microbiol Clin 2010; 28:104-9.301. Kropec A, Huebner J, Wursthorn M, Daschner FD. In vitro activity of vancomycin and teicoplanin againstStaphylococcus aureus and Staphylococcus epidermidis colonizing catheters. Eur J Clin Microbiol Infect Dis1993; 12:545-8.302. Lee JY, Ko KS, Peck KR, Oh WS, Song JH. In vitro evaluation of the antibiotic lock technique (ALT) for thetreatment of catheter-related infections caused by staphylococci. J Antimicrob Chemother 2006; 57:1110-5.303. Drago L, De VE, Valli M, Nicola L, Gismondo MR. Effect of linezolid in comparison with that ofvancomycin on glycocalix production: in vitro study. Antimicrob Agents Chemother 2002; 46:598-9.304. Gander S, Hayward K, Finch R. An investigation of the antimicrobial effects of linezolid on bacterial biofilmsutilizing an in vitro pharmacokinetic model. J Antimicrob Chemother 2002; 49:301-8.305. Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E. Linezolid compared with eperezolid, vancomycin,and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venouscatheter-related biofilm infections. Antimicrob Agents Chemother 2003; 47:3145-8.306. Rodríguez-Martínez JM, Ballesta S, García I, Conejo MC, Pascual A. [Activity and penetration of linezolidand vancomycin against Staphylococcus epidermidis biofilms]. Enferm Infecc Microbiol Clin 2007; 25:425-8.307. Castagnola E, Moroni C, Gandullia P, et al. Catheter lock and systemic infusion of linezolid for treatment ofpersistent Broviac catheter-related staphylococcal bacteremia. Antimicrob Agents Chemother 2006; 50:1120-1.308. Fennell JP, O'Donohoe M, Cormican M, Lynch M. Linezolid lock prophylaxis of central venous catheterinfection. J Med Microbiol 2008; 57:534-5.309. LaPlante KL, Mermel LA. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcalbiofilms in a central venous catheter model. Nephrol Dial Transplant 2007; 22:2239-46.310. Raad I, Hanna H, Jiang Y, et al. Comparative activities of daptomycin, linezolid, and tigecycline againstcatheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. AntimicrobAgents Chemother 2007; 51:1656-60.311. Bookstaver PB, Williamson JC, Tucker BK, Raad II, Sherertz RJ. Activity of novel antibiotic lock solutions ina model against isolates of catheter-related bloodstream infections. Ann Pharmacother 2009; 43:210-9.312. Aslam S, Trautner BW, Ramanathan V, Darouiche RO. Pilot trial of N-acetylcysteine and tigecycline as acatheter-lock solution for treatment of hemodialysis catheter-associated bacteremia. Infect Control HospEpidemiol 2008; 29:894-7.313. Grau S, Gil MJ, Mateu-de AJ, Pera M, Marin-Casino M. Antibiotic-lock technique using daptomycin forsubcutaneous injection ports in a patient on home parenteral nutrition. J Infect 2009; 59:298-9.314. Qu Y, Istivan TS, Daley AJ, Rouch DA, Deighton MA. Comparison of various antimicrobial agents ascatheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms. JMed Microbiol 2009; 58:442-50.